JPS6327360B2 - - Google Patents

Info

Publication number
JPS6327360B2
JPS6327360B2 JP53151163A JP15116378A JPS6327360B2 JP S6327360 B2 JPS6327360 B2 JP S6327360B2 JP 53151163 A JP53151163 A JP 53151163A JP 15116378 A JP15116378 A JP 15116378A JP S6327360 B2 JPS6327360 B2 JP S6327360B2
Authority
JP
Japan
Prior art keywords
cells
acid
polypeptides
ala
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP53151163A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5498719A (en
Inventor
Goorudosutain Gideon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ortho Pharmaceutical Corp
Original Assignee
Ortho Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/960,550 external-priority patent/US4232008A/en
Application filed by Ortho Pharmaceutical Corp filed Critical Ortho Pharmaceutical Corp
Publication of JPS5498719A publication Critical patent/JPS5498719A/ja
Publication of JPS6327360B2 publication Critical patent/JPS6327360B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1021Tetrapeptides with the first amino acid being acidic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C07K7/062Serum thymic factor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP15116378A 1977-12-08 1978-12-08 Novel tetrapeptide and its method Granted JPS5498719A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US85849677A 1977-12-08 1977-12-08
US94053178A 1978-09-08 1978-09-08
US05/960,550 US4232008A (en) 1978-11-17 1978-11-17 Tetrapeptides and methods

Publications (2)

Publication Number Publication Date
JPS5498719A JPS5498719A (en) 1979-08-03
JPS6327360B2 true JPS6327360B2 (sv) 1988-06-02

Family

ID=27420392

Family Applications (1)

Application Number Title Priority Date Filing Date
JP15116378A Granted JPS5498719A (en) 1977-12-08 1978-12-08 Novel tetrapeptide and its method

Country Status (19)

Country Link
JP (1) JPS5498719A (sv)
CA (1) CA1120031A (sv)
CH (1) CH642058A5 (sv)
DE (1) DE2853002A1 (sv)
DK (1) DK149595C (sv)
ES (1) ES475857A1 (sv)
FI (1) FI67368C (sv)
FR (1) FR2411174A1 (sv)
GB (1) GB2014581B (sv)
GR (1) GR65013B (sv)
IE (1) IE47611B1 (sv)
IL (1) IL56150A (sv)
IT (1) IT1110889B (sv)
NL (1) NL7812004A (sv)
NO (1) NO149631C (sv)
NZ (1) NZ189101A (sv)
PT (1) PT68883A (sv)
SE (1) SE444687B (sv)
YU (1) YU41322B (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4215112A (en) * 1979-03-14 1980-07-29 Ortho Pharmaceutical Corporation Tripeptides and methods
US4215111A (en) * 1979-03-14 1980-07-29 Ortho Pharmaceutical Corporation Peptides having ubiquitin-like activity
CA1156220A (en) * 1979-04-26 1983-11-01 George Heavner Method and composition for preparation of h-sar-lys-sar-gln-nh.sub.2
US4426324A (en) * 1979-09-28 1984-01-17 Hoffmann-La Roche Inc. Immunopotentiating peptides
JPS5711950A (en) 1980-06-25 1982-01-21 Kureha Chem Ind Co Ltd Peptide and its synthesis
FR2546164B1 (fr) * 1983-05-16 1987-07-17 Centre Nat Rech Scient Nouveaux derives de peptides, leur preparation et leur application comme inhibiteurs de l'elastase
FR2741076B1 (fr) 1995-11-15 1998-01-30 Rech De Pathologie Appliquee S Conjugues peptidiques derives des hormones thymiques, leur utilisation a titre de medicament et compositions les contenant
RU2210382C1 (ru) * 2002-07-09 2003-08-20 Терентьев Александр Александрович Пептид, обладающий иммунорегуляторным свойством, и его композиция

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2544348C3 (de) * 1975-10-03 1979-12-13 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen L-Leucin-13-Motilin, Verfahren zu dessen Herstellung und dasselbe enthaltendes Mittel
IT1156766B (it) * 1977-05-25 1987-02-04 Anvar Polipeptidi dotati di attivita' timica o antagonista e procedimento per la loro sintesi
FR2391994A1 (fr) * 1977-05-25 1978-12-22 Anvar Nouveaux polypeptides a activite thymique ou a activite antagoniste et leurs procedes de synthese
FR2423481A2 (fr) * 1978-04-21 1979-11-16 Anvar Nouveaux polypeptides a activite thymique ou a activite antagoniste et leurs procedes de synthese

Also Published As

Publication number Publication date
NO784128L (no) 1979-06-11
GB2014581B (en) 1982-05-19
FR2411174A1 (fr) 1979-07-06
NZ189101A (en) 1984-07-06
DK554078A (da) 1979-06-09
IT7852239A0 (it) 1978-12-07
IE47611B1 (en) 1984-05-02
YU288078A (en) 1983-02-28
NO149631C (no) 1984-05-23
FR2411174B1 (sv) 1984-05-25
PT68883A (en) 1979-01-01
FI783769A (fi) 1979-06-09
IT1110889B (it) 1986-01-06
ES475857A1 (es) 1980-01-16
SE7812614L (sv) 1979-06-09
FI67368B (fi) 1984-11-30
DE2853002A1 (de) 1979-06-13
FI67368C (fi) 1985-03-11
NO149631B (no) 1984-02-13
GB2014581A (en) 1979-08-30
DK149595B (da) 1986-08-04
JPS5498719A (en) 1979-08-03
CA1120031A (en) 1982-03-16
NL7812004A (nl) 1979-06-12
IL56150A0 (en) 1979-03-12
IE782423L (en) 1979-06-08
DK149595C (da) 1987-03-23
GR65013B (en) 1980-06-12
SE444687B (sv) 1986-04-28
YU41322B (en) 1987-02-28
CH642058A5 (de) 1984-03-30
IL56150A (en) 1982-02-28

Similar Documents

Publication Publication Date Title
US4190646A (en) Polypeptide compositions and methods
HU205142B (en) Process for producing peptides having t cell helper activity and pharmaceutical compositions comprising same
US4002740A (en) Tridecapeptide compositions and methods
EP0016611B1 (en) Tripeptides, process for their preparation, therapeutic compositions containing them and methods for their use
JPS61218598A (ja) バ−ソポイエチン
US4215111A (en) Peptides having ubiquitin-like activity
US4190647A (en) Polypeptides and methods
JPS6327360B2 (sv)
CA1105925A (en) Pentapeptide compositions and methods
EP0018182A1 (en) Peptides having thymopoietin-like activity, therapeutic compositions containing them, and process for their preparation
CA1105923A (en) Pentapeptides and methods
EP0723454B1 (en) Novel tripeptides useful in immune and cns therapy
US4258151A (en) Pentapeptide modified resin
HU205143B (en) Process for producing peptides having t cell suppressor activity and pharmaceutical compositions comprising same
US4232008A (en) Tetrapeptides and methods
US4258152A (en) Pentapeptide modified resin
GB1565032A (en) Polypeptide compositions and methods for their manufacture
GB1585736A (en) Polypeptides and methods for their production